Clinical trial
A Randomized, Controlled Trial of Ganaxolone in Adult Uncontrolled Partial-Onset…
NCT00465517 · Marinus Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00465517 |
|---|---|
| Title | A Randomized, Controlled Trial of Ganaxolone in Adult Uncontrolled Partial-Onset Seizures |
| Official title | A Double-blind, Randomized, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Efficacy of Ganaxolone as add-on Therapy in Adult Subjects With Epilepsy Consisting of Uncontrolled Partial-onset Seizures. |
| Lead sponsor | Marinus Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Partial Epilepsy, Catamenial Epilepsy |
| Intervention type | Drug, Other |
| Interventions | Ganaxolone, Placebo |
| Enrollment | 147 |
| Start date | Feb 1, 2007 |
| Primary completion | Oct 1, 2008 |
| Completion | Nov 1, 2008 |
| First posted | Apr 25, 2007 |
| Last update posted | Mar 15, 2023 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: